<DOC>
	<DOCNO>NCT00483678</DOCNO>
	<brief_summary>RATIONALE : A couple therapy program may enhance intimacy reduce psychological distress patient prostate cancer partner . PURPOSE : This randomized clinical trial study well couple therapy enhances intimacy reduce psychological distress patient advance recurrent prostate cancer partner .</brief_summary>
	<brief_title>Couples Therapy Enhance Intimacy Between Patients With Advanced Recurrent Prostate Cancer Their Partners</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility Intimacy-Enhancing Couples Therapy ( IECT ) patient advanced recurrent prostate cancer partner . - Compare effect IECT v usual care patient ' partner ' level global psychological distress . - Compare effect IECT v usual care relationship intimacy participant . OUTLINE : This randomize , control , pilot , multicenter study . Patients stratify accord marital distress base partner ' score Abbreviated Dyadic Adjustment Scale ( high [ &lt; 21 ] v low [ ≥ 21 ] ) . Patients partner randomize 1 2 arm . - Arm I : Patients partner receive Intimacy-Enhancing Couples Therapy 6 week comprise follow four 90-minute session : Story Cancer ; Understanding Couple , Ways Relating Key Influences ; Intimacy ; Coping , Support , Adaptation . Patients partner complete treatment satisfaction questionnaires completion study intervention . - Arm II : Patients partner receive standard psychosocial care . All participant complete questionnaire assess psychological distress , intimacy , communication pattern , overall relationship adjustment/satisfaction baseline 1 month completion study intervention .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis primary prostate cancer Advanced recurrent disease Receiving concurrent hormonal therapy Married and/or cohabitating partner ≥ 1 year Tscore &gt; 50 Brief Symptom Inventory18 questionnaire ( patient and/or partner ) PATIENT CHARACTERISTICS : Normal cognitive functioning Able speak read English No significant hearing impairment would preclude study participation PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>sexual dysfunction</keyword>
	<keyword>sexuality reproductive issue</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>